Recruiting Lupus Studies in Huntington Park
A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus
The goal of this clinical trial is to see how well cenerimod reduces symptoms of Systemic Lupus Erythematosus in adult patients with moderate to severe symptoms. The main questions it aims to answer a...
A Study of Obexelimab in Patients With Systemic Lupus Erythematosus
This study aims to examine the efficacy and safety of obexelimab in participants with systemic lupus erythematosus (SLE)....
About Lupus Clinical Trials in Huntington Park
Systemic lupus erythematosus (SLE) is a chronic autoimmune disease that can affect the joints, skin, kidneys, brain, and other organs. It is more common in women and often involves periods of flares and remission. Treatment includes antimalarials, immunosuppressants, and biologics.
There are currently 2 lupus clinical trials recruiting participants in Huntington Park, CALIFORNIA. These studies are seeking a combined 610 participants. Research is being sponsored by Viatris Innovation GmbH, Zenas BioPharma (USA), LLC. Clinical trial participation is free and participants receive study-related medical care at no cost.
Lupus Clinical Trials in Huntington Park — FAQ
Are there lupus clinical trials in Huntington Park?
Yes, there are 2 lupus clinical trials currently recruiting in Huntington Park, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Huntington Park?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Huntington Park research site will contact you about next steps.
Are clinical trials in Huntington Park free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Huntington Park studies also compensate for your time and travel.
What lupus treatments are being tested?
The 2 active trials in Huntington Park are testing new therapies including novel drugs, biologics, and treatment approaches for lupus.
Data updated March 2, 2026 from ClinicalTrials.gov